2005 Fiscal Year Final Research Report Summary
Roles of IGF-I receptor on intrauterine and postnatal growth
Project/Area Number |
16591028
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | National University Corporation Tottori University |
Principal Investigator |
KANZAKI Susumu Tottori University, Faculty of Medicie, Professor, 医学部, 教授 (90224873)
|
Co-Investigator(Kenkyū-buntansha) |
NAGATA Ikuo Tottori University, Faculty of Medicie, Associate Professor, 医学部, 助教授 (50252846)
NAGAISHI Jun-ichi Tottori University, University Hospital, Assistant Professor, 医学部附属病院, 助手 (90346354)
HANAKI Keiichi Tottori University, Faculty of Medicie, Professor, 医学部, 教授 (20238041)
|
Project Period (FY) |
2004 – 2005
|
Keywords | insulin-like growth factor / IGF-I / IUGR / IGF-I receptor / insulin receptor / IUGR short stature |
Research Abstract |
We hypothesized that mutations of insulin-like growth factor (IGF) receptor type 1 (IGF-IR) gene might predispose to short stature and associated with intrauterine growth retardation (IUGR). Until now we have analyzed the nucleotide sequences of IGF-IR gene in 28 patients with IUGR short stature. Among them we found two patients with IGF-IR gene mutation ; a heterozygous mutation (R709Q) at the cleavage site of IGF-IR and a heterozygous missense mutation at a subunit of IGF-IR (R431L). A heterozygous mutation (R709Q) changing the cleavage site from Arg-Lys-Arg-Arg to Arg-Lys-Gln-Arg was identified in a 6-year-old Japanese girl and her mother who also had IUGR short stature. Fibroblasts from the patient contained more unprocessed IGF-IR proreceptor protein and less mature β subunit protein compared to normal fibroblasts. These findings strongly suggest that this mutation lead to failure of processing from IGF-IR proreceptor to mature IGF-IR, and caused short stature and IUGR. A heterozygous missense mutation at a subunit of IGF-IR (R431L) mutation was identified in a 4-year-old Japanese girl with IUGR short stature and her mother who also had IUGR short stature. She was treated with growth hormone (GH) according to a clinical trial (0.25mg/kg/week), and her height has not improved significantly (from - 3.0 SD to -2.8 SD during 9 months) despite of GH therapy. R432 residue corresponds to L2 domain that is believed to be important for ligand binding. Accordingly, the mutation might cause decreased IGF-I binding, and IUGR short stature. In vitro studies using transfected cells with our IGF-IR mutation are warranted to clarify the exact mechanism of IGF-IR dysfunction. It is commonly believed that IGF-IR mutations are uncommon causes of IUGR short stature. However, our finding suggests that the actual prevalence of IGF-IR mutations in IUGR short stature might be considerably higher than previously thought.
|
Research Products
(15 results)